Velzen Pharma Pvt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VELZEN PHARMA PVT, and what generic and branded alternatives to VELZEN PHARMA PVT drugs are available?
VELZEN PHARMA PVT has five approved drugs.
Summary for Velzen Pharma Pvt
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Velzen Pharma Pvt
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Velzen Pharma Pvt | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214950-001 | Jan 30, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Velzen Pharma Pvt | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 214950-002 | Jan 30, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Velzen Pharma Pvt | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 211618-001 | Mar 1, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Velzen Pharma Pvt | GLYCOPYRROLATE | glycopyrrolate | TABLET;ORAL | 090195-002 | Sep 21, 2012 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Velzen Pharma Pvt | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 074045-001 | Apr 30, 1992 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
